Racial Differences in BRAF/KRAS Mutation Rates and Survival in Stage III Colon Cancer Patients.

BACKGROUND It is unknown if, after controlling for clinicopathologic variables and treatment, racial disparities in colon cancer outcomes persist. Molecular marker analysis in North American patients comparing Asians with other races has not been reported. METHODS BRAF (V600E) and KRAS mutations were analyzed in node-positive colon cancer patients (n… (More)